Robin Ciocca, DO
Surgical Oncology · Wynnewood, PANPI 1881809069
Payments from drug & device makers
What this record shows
20 manufacturers reported payments, led by Davol Inc. at 49.0% of the total. Reporting peaked in 2021 at $1,808 and has fallen 66.2% since, to $610 in 2025.
Across 75 payments — averaging $48.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$2K
- Lilly USA, LLC$331
- Eisai Inc.$304
- AstraZeneca$272
- Endomagnetics Ltd$182
- Stryker$173
- plus $611 from 14 others
What the payments were for
- Speaking & faculty fees$1,80049%
- Food & beverage$1,87351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 1 | $1,800 |
| Lilly USA, LLC | 16 | $331 |
| Eisai Inc. | 13 | $304 |
| AstraZeneca | 11 | $272 |
| Endomagnetics Ltd | 1 | $182 |
| Stryker | 1 | $173 |
| Bristol Myers Squibb | 8 | $159 |
| Sobi, Inc | 4 | $103 |
| Genentech USA, Inc. | 7 | $102 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Puma Biotechnology, Inc. | 1 | $29 |
| Merck | 1 | $27 |
| Medtronic | 1 | $21 |
| Edwards Lifesciences | 1 | $20 |
| KCI USA, Inc. | 1 | $20 |
| Seagen Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $13 |
| Hologic Inc | 1 | $12 |
| Elucent Medical | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Magseed$182
- Magtrace$182
- SPY-PHI SYSTEM$173
How this compares
$3,673 in reported general payments places this provider in the 70th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Wynnewood
- William MoranoWynnewood$11K
- Arvind SabesanWynnewood$10K
- Ned CarpWynnewood$3K
- Richard BleicherPhiladelphia$53K
- Catherine CarruthersSouthampton$17K
- Nestor EsnaolaPhiladelphia$17K
- Andrea PorpigliaPhiladelphia$11K
- Matthew HoltzmanPittsburgh$11K
- Stacy KrisherBensalem$9K
- Amer ZureikatPittsburgh$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.